Table 3. Cerebrospinal fluid biomarkers of white matter damage, amyloid-β (Aβ), and neuronal injury in mild dementia (i.e., MCI) and AD compared with cognitively normal individuals.
Mild dementia | AD | |
---|---|---|
White matter damage | ||
MBP | No existing literature | No change162, 179 |
MAG | No existing literature | No existing literature |
Aβ peptide | ||
Aβ-42 | ↓Downregulation141, 183 | ↓Downregulation130, 148, 184 |
Neuronal injury | ||
Total tau | ↑Upregulation141, 183 | ↑Upregulation130, 148, 184 |
pTau | ↑Upregulation183, 187 | ↑Upregulation130, 184 |
NSE | No existing literature | No change162 ↑Upregulation192, 193 |
Neurofilament-L | No existing literature | ↑Upregulation190, 191 |
Abbreviations: AD, Alzheimer's disease; Aβ, amyloid-β; MAG, myelin-associated glycoprotein; MBP, myelin basic protein; MCI, mild cognitive impairment; NSE, neuron-specific enolase; pTau, phosphorylated tau.